Bob Hopkins is a Managing Director at Bank of America Merrill Lynch. Since joining BofAML, he has served as the firm’s senior U.S. medical technology equity research analyst covering both large and mid cap stocks within the cardiovascular, orthopedic, general surgery, robotic, and medical supply spaces. For the last twelve years Bob has been ranked as a top medical device analyst as per the annual Institutional Investor Magazine’s poll, which surveys the largest institutional money managers and hedge funds each year to assess which sell side analysts add the most value. Before joining BofAML, Bob followed the medical device space for DLJ and Lehman Brothers. He has covered the medical device space since 1998 and Bob’s current coverage list includes names such as Abbott, Baxter, Boston Scientific, Cardiovascular Systems, CR Bard, Edwards Life Sciences, Entellus, Glaukos, Globus Spine, Hill-Rom, Intersect ENT, Integra, Intuitive Surgical, J&J, Medtronic, Nevro, NuVasive, Penumbra, Stryker, Tandem, Wright Medical and ZimmerBiomet.
Bob graduated from Trinity College in Hartford, CT in 1989 and received his MBA from Columbia University in NY in 1995. Bob has built up a strong reputation for his long standing clinical contacts, his independent research and his industry knowledge. His phone number in NY is 646-855-3131 and his email address is email@example.com.